Olympus Partners scoops up generic drug maker PAI Pharma

Kurt Orlofski serves as CEO of PAI.

13 February 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.